Logo

Stratagene, Rosetta Inpharmatics to Co-Develop RNA Purification System

Aug 14, 2006

NEW YORK (GenomeWeb News) – Stratagene said today that it has formed a joint development and license agreement with Rosetta Inpharmatics to create automated solution for the isolation of nucleic acids from clinical samples.

Under the deal, the companies will jointly develop an instrument and a single-use consumable, which will be manufactured Stratagene for sale to its customers engaged in pharmacogenomics.

Additional terms of the agreement were not disclosed.

Breaking News
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.